Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0390220220330020044
Journal of Clinical Otolaryngology, Head and Neck Surgery
2022 Volume.33 No. 2 p.44 ~ p.52
Biological Therapy in Refractory Chronic Rhinosinusitis with Nasal Polyp
Yang Seung-Koo

Kim Dae-Woo
Abstract
Chronic rhinosinusitis with nasal polyp (CRSwNP) can be controlled with medication or surgical treatment, yet limitations exist, and biologics can be an effective alternative for uncontrolled severe CRSwNP patients with poor response to traditional medication and multiple surgeries. In order to better understand the role of biologics in CRSwNP, pharmacokinetics and pharmacodynamics of monoclonal antibodies and local, systemic pathophysiology of CRSwNP in blood vessel, sinus mucosa, and nasal polyp are explored and explained in terms of pathomechanism of each biologic.
KEYWORD
Antibodies, monoclonal, Nasal polyps, Immunology
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)